These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3671896)

  • 41. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
    Inbar S; Schrader BJ; Kaufmann E; Vestal RE; Rich S
    J Am Coll Cardiol; 1993 Feb; 21(2):413-8. PubMed ID: 8426006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet.
    Dickstein PJ; Trindade O; Goldberg RN; Bancalari E
    Pediatr Res; 1984 Dec; 18(12):1262-5. PubMed ID: 6522139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NIP-121 is more effective than nifedipine in acutely reversing chronic pulmonary hypertension.
    Oka M; Morris KG; McMurtry IF
    J Appl Physiol (1985); 1993 Sep; 75(3):1075-80. PubMed ID: 8226514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of inhaled nitric oxide on hemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease.
    Moinard J; Manier G; Pillet O; Castaing Y
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1482-7. PubMed ID: 8004302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxic pulmonary vasoconstriction and pulmonary gas exchange in normal man.
    Mélot C; Naeije R; Hallemans R; Lejeune P; Mols P
    Respir Physiol; 1987 Apr; 68(1):11-27. PubMed ID: 3602609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic effects of nifedipine in normoxic and hypoxic newborn lambs.
    Philips JB; Lyrene RK; Leslie GI; McDevitt M; Cassady G
    Pediatr Pharmacol (New York); 1985; 5(1):23-30. PubMed ID: 3991251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
    Rich S; Ganz R; Levy PS
    Am J Cardiol; 1983 Nov; 52(8):1104-7. PubMed ID: 6637831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon.
    Fisher J; Mack RJ; Likier HM; Schiff AN; Borer JS
    Chest; 1987 Sep; 92(3):400-5. PubMed ID: 3622018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of hypoxic pulmonary vasoconstriction by almitrine in the dog.
    Romaldini H; Rodriguez-Roisin R; Wagner PD; West JB
    Am Rev Respir Dis; 1983 Aug; 128(2):288-93. PubMed ID: 6136245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term beneficial effect of nifedipine in primary pulmonary hypertension.
    Lunde P; Rasmussen K
    Am Heart J; 1984 Aug; 108(2):415-6. PubMed ID: 6464979
    [No Abstract]   [Full Text] [Related]  

  • 51. Polycythemia impairs vasodilator response to acetylcholine in patients with chronic hypoxemic lung disease.
    Defouilloy C; Teiger E; Sediame S; Andrivet P; Roudot-Thoraval F; Chouaid C; Housset B; Adnot S
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1452-60. PubMed ID: 9603123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nifedipine in the treatment of pulmonary hypertension. II--Hypoxic pulmonary hypertension].
    Barreto BM; de Freitas FM
    Arq Bras Cardiol; 1986 Jun; 46(6):425-9. PubMed ID: 3579636
    [No Abstract]   [Full Text] [Related]  

  • 53. [Modification of pulmonary hypertension in patients with chronic obstructive lung diseases using calcium antagonists in an acute trial].
    Schauer J; Himmel W; Orschekowski H
    Z Gesamte Inn Med; 1989 Jan; 44(2):50-4. PubMed ID: 2650472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of nifedipine on pulmonary hypertension in patients with chronic obstructive pulmonary diseases--a comparison with oxygen administration].
    Liu Z; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Jun; 14(3):146-8, 189. PubMed ID: 1913960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral nifedipine in chronic cor pulmonale secondary to severe chronic obstructive pulmonary disease (COPD).
    Sturani C; Bassein L; Schiavina M; Gunella G
    Chest; 1983 Aug; 84(2):135-42. PubMed ID: 6872591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemodynamic effects of sublingual nifedipine in acute myocardial infarction.
    Gordon GD; Mabin TA; Isaacs S; Lloyd EA; Eichler HG; Opie LH
    Am J Cardiol; 1984 May; 53(9):1228-32. PubMed ID: 6143505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary vascular tone is increased by a voltage-dependent calcium channel potentiator.
    Tolins M; Weir EK; Chesler E; Nelson DP; From AH
    J Appl Physiol (1985); 1986 Mar; 60(3):942-8. PubMed ID: 2420778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
    Bando M; Ishii Y; Kitamura S; Ohno S
    Respiration; 1998; 65(1):63-70. PubMed ID: 9523370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paradoxical elevation of pulmonary vascular resistance after nifedipine in primary pulmonary hypertension. A case study.
    Pohar B; Grad A; Mozina M; Rakovec P; Horvat M
    Cor Vasa; 1989; 31(3):238-41. PubMed ID: 2766755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
    Hedelin P; Kylhammar D; Rådegran G
    Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.